What Cells Can I Use with MaxCyte®'s Electroporation Platform?
MaxCyte's electroporation platform supports an extensive variety of cell types, from primary and stem cells to immune and tumor cells, enabling high transfection efficiency with exceptional viability.
Our proven expertise across these cell types ensures that no matter your application, MaxCyte delivers the precision and scalability you need to advance your cell engineering goals.
MaxCyte has the industry-leading electroporation technology devised to enable the development of an engineered cell therapy using patient cells. We created a system with fragile cells in mind, using clinical-grade, non-toxic components. Our system prioritizes the handling of fragile cells, integrating clinical-grade, non-toxic components for optimal performance.
With decades of expertise in cell handling, we offer tailored, cell-specific electroporation protocols to ensure exceptional efficiency and viability across all cell types. At MaxCyte, we know that the cells you choose matter, which is why our technology consistently delivers unmatched transfection results and superior cell health.
Explore the cell types below—if your cells aren't listed, partner with MaxCyte's expert scientists, leveraging decades of experience to optimize cell engineering with our advanced, tailored protocols.
